Bromfenac is a nonsteroidal anti-inflammatory drug (NSAID) for ophthalmic use. Ophthalmic NSAIDs are becoming a cornerstone for the management of ocular pain and inflammation. Their well-characterized anti-inflammatory activity, analgesic property, and established safety record have also made NSAIDs an important tool for optimizing surgical outcomes. Non-ophthalmic formulations of bromfenac were withdrawn in the US in 1998 due to cases of severe liver toxicity.[L43942,T239]
Synonyms
[2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid
2-amino-3-(4-bromobenzoyl)benzeneacetic acid
Bromfenac
Bromfenacum
Bromfenac sodium
Bromfenaco
Brand Names
Bromsite 0.075%
Bromday
Pred Phos - Brom
Auro-bromfenac
Bromfenac
Bromfenac Sodium
Pred-Gati-Brom
Xibrom
Apo-bromfenac
Pred Phos-Gati-Brom
Prolensa
Pred-Brom
Bromfenac Ophthalmic Solution, 0.09%
Bromfenac 0.075%
Bromfenac Ophthalmic Solution
Bromfenac Ophthalmic Solution 0.09%
Yellox
Indication
For the treatment of postoperative inflammation in patients who have undergone cataract extraction.
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682